During the past decade, Abrams Eye Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Abrams Eye Center" #1 sponsor was "Kala Pharmaceuticals, Inc." with 3 trials, followed by "Merck Sharp & Dohme LLC" with 3 trials sponsored, "Santen Inc." with 3 trials sponsored, "RVL Pharmaceuticals, Inc." with 2 trials sponsored and "Aerie Pharmaceuticals" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

According to Clinical.Site data, the most researched conditions in "Abrams Eye Center" are "Dry Eye" (4 trials), "Keratoconjunctivitis Sicca" (3 trials), "Ocular Hypertension" (3 trials), "Blepharitis" (2 trials) and "Blepharoptosis" (2 trials). Many other conditions were trialed in "Abrams Eye Center" in a lesser frequency.

Most popular intervention types in "Abrams Eye Center" are "Drug" (21 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Vehicle" (3 trials), "DE-117 Ophthalmic Solution" (2 trials), "KPI-121" (2 trials) and "Placebos" (2 trials). Other intervention names were less common.

The vast majority of trials in "Abrams Eye Center" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Abrams Eye Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Abrams Eye Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Abrams Eye Center, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".